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Abstract. We describe a novel one-step reverse transcriptase real-time PCR (direct RT-PCR) for Plasmodium
falciparum malaria parasites that ampliﬁes RNA targets directly from blood. We developed the assay to identify
gametocyte-speciﬁc transcripts in parasites from patient blood samples, as a means of monitoring malaria parasite
transmission in ﬁeld settings. To perform the test, blood is added directly to a master mix in PCR tubes and analyzed
by real-time PCR. The limit of detection of the assay on both conventional and portable real-time PCR instruments
was 100 parasites/mL for 18S rRNA, and 1,000 parasites/mL for asexual (PFE0065W) and gametocyte (PF14_0367,
PFGEXP5) mRNA targets. The usefulness of this assay in ﬁeld studies was explored in samples from individuals living
in a high-transmission region inCameroon. The sensitivity and speciﬁcity of the assay comparedwith a standard two-
step RT-PCRwas 100% for 18S rRNA on both conventional and portable instruments. For PF14_0367, the sensitivity
and speciﬁcity were 85.7% and 70.0%, respectively, on the conventional instrument and 78.6% and 90%, re-
spectively, on the portable instrument. The concordance for assays run on the two instruments was 100% for 18S
rRNA, and 79.2% for PF14_0367, with most discrepancies resulting from samples with low transcript levels. The
results show asexual and sexual stage RNA targets can be detected directly from blood samples in a simple one-step
test on a ﬁeld-friendly instrument. This assay may be useful for monitoring malaria parasite transmission potential in
elimination settings, where sensitive diagnostics are needed to evaluate the progress of malaria eradication
initiatives.
INTRODUCTION
Malaria is a disease of global concern that has been met
with concerted efforts to move countries toward disease
control, regional elimination, and ultimately global eradi-
cation.1 In 2015, an estimated 212 million malaria cases
occurred globally, resulting in 429,000 deaths. Since 2000,
malaria case incidence and mortality were reduced by 41%
and 62%, respectively, mostly from the broad imple-
mentation of malaria control interventions.2 Signiﬁcant
progress toward elimination has also been achieved, with
17 countries reaching elimination status between 2000 and
2015. In 2015, an additional 19 countries reported 1,000 or
fewer indigenous cases, at least 10 of these being on track
for elimination status by 2020.2 However, many challenges
to achieve and sustain elimination status remain,3 not the
least of which is preventing the highly efﬁcient transmission
of malaria parasites by mosquitoes.4 The potential for on-
going transmission partly stems from the high proportion of
submicroscopic infections that remain undetected in set-
tings where malaria parasite transmission intensity is
reduced.5,6 Current diagnostic techniques, such as light
microscopy and rapid diagnostic tests (RDTs), do not have
the sensitivity to detect all infections.7 Molecular methods
have been developed with increased sensitivity, but these
methods remain to be implemented routinely within elimi-
nation programs.8
Although there is sufﬁcient evidence that submicroscopic
infections contribute to malaria parasite transmission in some
settings of intense malaria parasite transmission,9 this
evidence is inconclusive in settings of lower endemicity.10–12
Mature, infectious gametocytes are present in the majority of
symptomatic and asymptomatic malaria infections, often at
low concentrations.13 Transmissibility or infectiousness to
mosquitoes is increasingly appreciated as a complex phe-
nomenon, related in a nonlinear manner to parasite density,
varying independently of transmission intensity, and inﬂu-
enced by human immune responses and vector sus-
ceptibility to infection.6 Despite these issues, monitoring
submicroscopic infections, particularly gametocytes, remains
of central importance to broaden our understanding of trans-
mission dynamics in low-endemic elimination settings. Pres-
ently, there are few tools available to accomplish this goal,
especially in ﬁeld settings.
Molecular diagnostic tools such as nucleic acid tests
provide themost accurate epidemiological data in all aspects
of malaria control. In elimination settings, implementation of
these tests for surveillance may support the prevention of
reintroduction of malaria.8 For monitoring transmission
potential, RNA-based testing shows particular promise, in-
cluding reverse transcriptase polymerase chain reaction
(RT-PCR),14 quantitative nucleic acid sequence-based am-
pliﬁcation assay (QT-NASBA),15 and RT-loop-mediated iso-
thermal ampliﬁcation (RT-LAMP)16methods. The targeting of
sexual stage speciﬁc transcripts such as Pfs25,17,18
Pfs230,19 and Pfg37720 allows the detection of gametocytes
at unsurpassed sensitivity. The sensitivities of these meth-
ods are relatively high, reporting detection of Pfs25 at 20
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gametocytes/mL for bothQT-NASBAandRT-PCRdetection
of Pfs25.21,22 One drawback is the need for nucleic acid
puriﬁcation prior to ampliﬁcation, a step that is difﬁcult to
perform in the ﬁeld. For molecular diagnostics in general, the
cost and complexity of these tests has precluded their use in
low-resource settings.
We addressed these challenges in previous work by de-
veloping a PCR test for malaria parasites that does not require
nucleic acid puriﬁcation23 and incorporated this test into a
desiccated hydrogel matrix for use in a customized, portable
real-time PCR machine.24 In the present study, we describe
the development of an RT-PCR method to detect gameto-
cytes directly from small blood volumes in a one-tube assay.
The reaction involves the addition of blood directly to amaster
mix, reverse transcription of template RNA in the blood to
cDNA, followed by PCR ampliﬁcation of the cDNA template.
This reaction uses a commercial enzyme mixture for reverse
transcription and PCR that is resistant to inhibitors in blood.
The enzymes also tolerate a high concentration of SYBR
Green DNA intercalating dye, which is necessary to generate
sufﬁcient ﬂuorescence signal in the presence of blood. This
assay was optimized to detect 18S rRNA on a conventional
real-time PCR instrument and adapted for detection of a gene
expressed in mature gametocytes (PF14_0367).25 As a ﬁrst
step in showing the potential for this assay to detect game-
tocytes in the ﬁeld, we tested it on a blind panel of blood
samples from gametocytemic individuals from Cameroon
using a commercially available portable real-time PCR
instrument.
METHODS
Parasite cultures and parasite dilution series. Plasmo-
dium falciparum 3D7 strain MRA-102 was obtained from the
Malaria Research and Reference Reagent Resource Center
(BEI Resources, Manassas, VA) and grown in human eryth-
rocytes in vitro at 3% hematocrit as described.26 NF54 para-
sites were maintained in vitro in a semiautomated culture
system.27–29 Brieﬂy, parasites were grown in RPMI-1640medium
supplementedwith human serum (completemedium) and 5%
hematocrit (Sanquin) and medium was refreshed twice daily.
Plasmodium asexual parasites at 10% density were syn-
chronized by the selection of late trophozoites and schizonts
on a 63%Percoll density gradient. This was followed by a 5%
sorbitol treatment after 5 hours, killing the remaining schiz-
onts. Five hours later, samples containing early ring-stage
parasites were harvested. Gametocyte cultures were started
at 0.5% asexual parasitemia and treated with N-acetyl-
glucosamine on day 7 to eliminate asexual parasites.30,31
Stage V parasites were obtained on day 14. The presence of
asexual and sexual stage parasites was conﬁrmed on
Giemsa-stained slides, and parasite concentration was de-
termined using a Burker-Turk cell counting chamber. Ten-fold
serial dilutions of parasites were made in uninfected EDTA
blood to be used directly as templates in ampliﬁcation reac-
tions. Nucleic acid was puriﬁed from the dilution series by
MagNAPure LC Total Nucleic Acid Isolation Kit (Roche Mo-
lecular Biochemicals, Mannheim, Germany). Extracted
nucleic acid was treated with RQ1 DNase I (Promega, Madi-
son, WI) for 30minutes at 37C to remove genomic DNAwhile
keepingRNA intact. This puriﬁedRNAwasusedas template in
ampliﬁcation reactions.
Patient samples. Deidentiﬁed samples were used from a
separate study on the transmissibility of P. falciparum infec-
tions to Anopheles gambiae s.s. mosquitoes. All procedures
used in that study were approved by the Cameroonian
national ethical committee (2015/04/583/CE/CNERSH/SP)
that monitored progress in annual reports. Caretakers of
study participants provided written informed consent prior to
inclusion in the study.Microscopically detectable gametocyte
carriers aged 5–15 years were recruited from schools and
communities surrounding Yaounde´, Cameroon, as described
previously.32 Whole blood samples collected by venipuncture
into heparinized tubes were stored directly at _80C prior to
use in the assay. Asexual and sexual stage densities were
estimated in Giemsa-stained thick smears by counting para-
site numbers per thousand white blood cells (WBCs), and
converting to a density value assuming the standard of
8,000WBC/μL of blood. For this cohort, values ranged from
8–1,496 gametocytes/μL of blood, with a median value
of 80 gametocytes/μL and a standard deviation of 332
gametocytes/μL. From cohort members for whom ³ 1 mL of
whole blood was remaining after transmissibility assess-
ments, 1 mL blood samples were anonymized prior to ship-
ment to Alberta, Canada. Participants gave explicit consent
for their material to be analyzed outside Cameroon.
Direct RT-PCR assay. The direct RT-PCR was performed
in a 25 μL reaction containing 1× blood RT-PCR buffer, 0.5 μL
RT polymerase mix (Direct Blood RT-PCR kit; VitaNavi Tech-
nology, Manchester, MO), 40× SYBR Green (Thermo Fisher
Scientiﬁc, Waltham, MA), 1 μL Ribolock RNase Inhibitor
(Thermo Fisher Scientiﬁc), and primers at a ﬁnal concentration
of 200 nM, with the exception of the PFGEXP5 primers, which
were used at a ﬁnal concentration of 400 nM (Table 1). A new 59
TABLE 1
Primers used in this study
Target DNA sequence (59–39) Reference
18S rRNA forward GCCGTTTTTAGTTCGTGAAT This study
18S rRNA reverse GCAGGTTAAGATCTCGTTCG This study
Pf_A18S_fw TCCGATAACGAACGAGATCTTAAC 22
Pf_A18S_rev ATGTATAGTTACCTATGTTCAATTTCA 22
PF14_0367 forward GTTACATTTCGACCCAGCATAAATT 25
PF14_0367 reverse TCCCTGTGTTTTTGCTCATCTTC 25
PFE0065w forward GCAAAACAAGCCGTACATGTTG 25
PFE0065w reverse TTGCTAGGTAATATCCTTTTCTTTTTCC 25
PFGEXP5 forward GGGCTGTTATGTATATTTTTATTGAATTTT This study
PFGEXP5 reverse CATTCGTTTCATTTTCACCACTTC This study
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consensus primer was designed for 18S rRNA ampliﬁcation;
the 18S rRNA 39 consensus primer is a modiﬁed sequence
from a previous study.33 This primer set reduces nonspeciﬁc
ampliﬁcation that may originate from off-target primer in-
teractions in the reverse transcription step. The blood com-
ponent of the reactionmixture was added in a 2.5 μL volume,
either as uninfected blood controls, parasite serial dilutions
in blood, or patient blood samples. In experiments where
puriﬁed parasite RNA was tested, 2.5 mL puriﬁed RNA and
2.5 μL uninfected blood were added to the reaction. Ther-
mocycling was performed in both conventional and portable
real-time PCR instruments. For the conventional instrument,
reactions were run in 96-well PCR plates on a Bio-Rad CFX
Connect Real-Time PCR Detection System (Bio-Rad Labo-
ratories, Inc., Hercules, CA) and in 200 μL low proﬁle PCR
8-strip tubes (BioRad) in theportable real-timePCR instrument
(Open qPCR, Chai Biotechnologies Inc, Santa Clara, CA).
The RT-PCR thermocycling program was as follows: 60C
reverse transcription for 30 minutes, 3 minute 95C de-
naturation, 45 cycles of 95C for 20 seconds, 60C for 30
seconds, 70C for 30 seconds, 2 minute 70C ﬁnal extension,
and melt curve analysis from 65C to 95C.
The 18S rRNA and PF14_0367 RT-PCR assays were per-
formed in duplicate on patient samples in the clinical panel, in
both the conventional and portable real-time PCR instru-
ments. For 18S rRNA and PF14_0367 in the conventional
instrument and 18S rRNA in the portable instrument, 1×
enzyme concentration was used. Both 1× and 5× enzyme
concentrations were compared for the initial optimization of
PF14_0367 in the portable instrument and 5× enzyme con-
centration was used to run the clinical samples on this
instrument.
A two-stepRT-PCRwas performed as a reference standard
for assessing the performance of the direct RT-PCR with
samples from the clinical panel. In the ﬁrst step, RNA was
puriﬁed from patient blood samples as described earlier and
reverse transcribed (High capacity cDNA Reverse Transcrip-
tion Kit; Thermo Fisher Scientiﬁc). The resulting cDNA was
used in the second step as template for quantitative PCR
using the GoTaq qPCR master mix and Bryt Green dye
(Promega) on the BioRadCFX instrument. Duplicate reactions
were performed using primers targeting 18S rRNA (Pf_A18S
fwand rev in Table 1) andPF14_0367 (Table 1). Thermocycling
conditions included an initial denaturation of 95C for 2 min-
utes followedby40cyclesof 95C for 15 secondsand60Cfor
1 minute.
Data analysis. BioRad CFX Manager 3.1 software was
used for conventional RT-PCR post-ampliﬁcation data anal-
ysis. Quantiﬁcation cycle (Cq) determination mode was set to
single threshold with baseline-subtracted curve ﬁt and a user-
deﬁned threshold of 50 relative ﬂuorescence units (RFUs) for
analysis of parasite serial dilutions in blood. The limit of de-
tection (LOD) of the assay was deﬁned as the lowest parasite
dilution that met the following criteria: 1) at least two of three
curves crossing the threshold at or before the cycle cutoff
value of 40 cycles for 18S rRNA and 45 cycles for all other
targets; and 2) melting temperatures (Tm) within acceptable
ranges as deﬁned by positive controls for 18S rRNA (76–79C)
and PF14_0367 (77–80C). The two-step RT-PCR reaction
usedasa reference standard in theclinical panelwasanalyzed
in the same way with a user-deﬁned threshold of 200 RFU.
Melt curve analysis was not performed for this reaction.
For the portable real-time PCR instrument, Open qPCR
software version 1.0.2 (Chai Biotechnologies Inc) was used for
post-ampliﬁcation analysis. Cq and Tm values were calcu-
lated directly by the instrument software and reported. The
software calculates Cq values for each individual curve by the
secondderivativemaximummethod, thus asingle threshold is
not used for all curves in the experiment (as in the commercial
instrument). Raw data output from the software was used
to generate ampliﬁcation curves (baseline subtracted RFU
versus PCR cycle) and melting curves (_d[RFU]/dT versus
temperature) in Microsoft Excel (Microsoft Corporation, Red-
mond,WA). The analytical sensitivity of the assaywas deﬁned
as earlier, with a Cq cutoff of 45 and a Tm within acceptable
ranges for 18S rRNA (76–80C) and PF14_0367 (78–80C).
The clinical sensitivity and speciﬁcity of the direct RT-PCR
assay for 18S rRNA and PF14_0367 transcripts on conven-
tional and portable instruments were calculated in compar-
ison to the reference standard RT-PCR. The concordance
and kappa statistic were also determined for both assays
between the conventional and portable instruments. For
the comparison of sensitivities and speciﬁcities of the
PF14_0367 assay on the two instruments, P values were
calculated using McNemar’s exact test, and the proportion of
agreement and 95% conﬁdence intervals were reported
(Supplemental Table 3).
RESULTS
Detection of parasite rRNA in a direct blood RT-
PCR reaction. To optimize the direct RT-PCR assay for de-
tection of RNA targets in blood, we chose P. falciparum 18S
small subunit rRNA, a commonly used target that we had
studiedpreviouslywith adirect-from-bloodPCRdiagnostic.23
For this target, there are 5–8 18S rRNA gene copies34 and
thousands of transcripts per cell.35 In the ﬁrst enzymatic step
of this reaction, the ribosomal RNA is reverse transcribed into
cDNA; in the second step, the 18S cDNA and 18S genomic
DNA serve as templates for the PCR reaction. The LOD of this
assay was ﬁrst evaluated for puriﬁed parasite RNA added to
blood. RNA was puriﬁed from 10-fold dilutions of ring-stage
parasites in uninfected blood, added to a new aliquot of un-
infected blood and tested by direct RT-PCR (Figure 1A andB).
The LODwas 10 parasites/mL blood, a value that exceeds the
sensitivity of microscopy (10,000–100,000 parasites/mL).36
Next, we tested the LOD with intact ring-stage parasites se-
rially diluted in uninfected blood and added directly to the
reaction (Figure 1C and D). In this case, the LOD was 100
parasites/mL. The difference in sensitivity may reﬂect the in-
creased availability of puriﬁed RNA compared with RNA re-
leased from infected red blood cells. Raw data and statistical
analysis of Cq values for the direct RT-PCR assay on the
conventional real-time PCR instrument are presented in
Supplemental Table 1.
Detection of mRNA by direct blood RT-PCR in
asexual parasites. In the 18S rRNA RT-PCR assay, ampli-
ﬁcation occurred from both rRNA and genomic DNA tar-
gets. To determine whether the assay can strictly detect
messenger RNA apart from the genomic DNA sequence, we
selected PFE0065w skeleton-binding protein 1 mRNA, a
target transcript expressed in ring-stage parasites.37 The
LOD for this target was 1,000 parasites/mL (Figure 2A and
B). The use of intron-spanning primers conﬁrmed that the
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reverse transcription step of the reaction was working, as
these primers speciﬁcally amplify only RNA.25 In addition,
we found that inclusion of RNase inhibitor was essential for
high sensitivity detection of RNA. Omitting RNase inhibitor
resulted in a decrease in signal for both puriﬁed RNA and
parasites added directly to the reaction (Supplemental
Figure 1).
MonitoringP. falciparumgeneexpression ingametocytes.
Next, we tested the direct RT-PCR reaction on parasite
sexual stage mRNA targets. These included sexual stage
transcripts from P. falciparum gametocyte exported protein-
5 (PFGEXP5)38 and PF14_0367.25 PFGEXP5 is one of the
earliest sexual stage markers identiﬁed to date, expressed
in sexually committed ring-stage parasites, whereas PF14_0367
is amature gametocytemarker of unknown function.25 The
LOD of the RT-PCR reaction for these targets in gameto-
cytes serially diluted in blood was 1,000 parasites/mL
(Figure 3). Although the assay has a similar sensitivity for
both asexual- and sexual-stage mRNA targets, the am-
pliﬁcation curves cross the threshold at different cycles,
reﬂecting the differences in the efﬁciencies of each primer
set and the abundance of these mRNA species. The melt
curves for both PFGEXP5 and PF14_0367 also displayed
some peaks that did not align with the major product peak,
indicating the presence of nonspeciﬁc ampliﬁcation with
these primers, mostly at the lower parasite concentra-
tions. Based on the relatively robust ampliﬁcation of
PF14_0367, we chose this as a candidate gametocyte
marker for further study. To conﬁrm that PF14_0367 was
expressed only in gametocytes, we compared expression
in puriﬁed asexual ring-stage parasites andmature stage V
gametocytes, showing increased levels of expression in
gametocytes (Figure 4). 18S rRNA expression, which is not
expected to differ between sexual and asexual stages,
was analyzed in parallel.
Performance of the direct blood RT-PCR assay on a
portable real-time PCR instrument. To evaluate the po-
tential of the direct RT-PCR assay to be used in ﬁeld settings,
we ran the assay on a portable 16-well real-time PCRmachine
(Open qPCR, Chai Biotechnologies, Inc). This instrument was
chosen for its ability to generate real-time PCR data, ease of
use, portability, and low cost. On this instrument, the RT-PCR
assay had a LOD of 100 parasites/mL for 18S rRNA, similar to
the conventional instrument, and 10,000 parasites/mL for
FIGURE 1. Plasmodium falciparum 18S rRNA detection in blood by direct reverse transcriptase polymerase chain reaction (RT-PCR). (A) Real-
time ampliﬁcation and (B) melting curves for 18S rRNA direct RT-PCR. Total nucleic acid was ﬁrst puriﬁed from serial dilutions of P. falciparum 3D7
ring-stage parasites in uninfected blood. This puriﬁed nucleic acidwas added back to blood in the direct RT-PCR reaction. (C) Ampliﬁcation and (D)
melting curves for 18S rRNA using the intact unpuriﬁed parasite serial dilutions in blood added directly to the reaction. The limit of detection for 18S
rRNA from puriﬁed parasite nucleic acid is 10 parasites/mL and from unpuriﬁed parasite serial dilutions is 100 parasites/mL. These reactions were
performed on a conventional real-time PCR instrument (Bio-RadCFXConnect) with a threshold setting of 50 relative ﬂuorescence units (horizontal
line). This ﬁgure appears in color at www.ajtmh.org.
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PF14_0367, 10-fold less sensitive than the conventional in-
strument (Figure 5). To boost the sensitivity of the reaction for
PF14_0367, we increased the enzyme levels in the reaction
5-fold, achieving a LOD of 1,000 parasites/mL (Figure 5E). Raw
data and statistical analysis of Cq values for the direct RT-PCR
assay on the portable real-time PCR instrument are presented
in Supplemental Table 2.
The blood RT-PCR assay can successfully identify ga-
metocytes in individuals from a high transmission setting.
The ability to detect gametocytes in patient blood samples is a
FIGURE 3. Detection of Plasmodium falciparum gametocyte mRNA targets in blood. (A) Real-time ampliﬁcation and (B) melting curves for
PF14_0367 mRNA direct reverse transcriptase polymerase chain reaction (RT-PCR). (C) Real-time ampliﬁcation and (D) melting curves for
PFGEXP5 mRNA direct RT-PCR. Both mRNA targets were detected in P. falciparum NF54 gametocyte serial dilutions on the conventional
instrument at a limit of detection of 1,000 parasites/mL. This ﬁgure appears in color at www.ajtmh.org.
FIGURE2. DetectionofPlasmodiumfalciparumPFE0065w (SBP1)mRNA fromasexual stages inblood. (A) Real-timeampliﬁcationand (B)melting
curves for PFE0065wmRNA direct reverse transcriptase polymerase chain reaction (RT-PCR) using P. falciparum 3D7 ring-stage serial dilutions in
blood. The limit of detection for PFE0065wmRNA is 1,000parasites/mL. This reactionwasperformed in the conventional real-timePCR instrument.
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signiﬁcant step toward developing a better diagnostic tool
for malaria parasite transmission. A blind panel of 24 blood
samples from individuals living in an area of high malaria
parasite transmission in Cameroon was tested for 18S rRNA
and PF14_0367 expression on conventional and portable
real-timePCR instruments (Table 2). Each samplewas tested
in duplicate; Cq values were returned for all 96 runs in the
conventional instrument and 93/96 runs in the portable in-
strument (Table 2). Two runs generated no Cq values despite
the presence of a curve andone run generated a lowCq value
that was considered an instrument Cq calculation error
based on examination of the ampliﬁcation curve. Cq values
for 18S rRNA expression suggest a signiﬁcant parasite bur-
den in the majority of patients. Negative controls showed
no ampliﬁcation for all targets and platforms. The sensitivity
and speciﬁcity for 18S rRNA andPF14_0367 assays on both
instruments were calculated in comparison to a standard
two-step RT-PCRmethod (Table 3). This method uses RNA
puriﬁed from the blood as a template and is considered a
highly sensitive and speciﬁc assay for parasite transcripts.
In both the conventional and portable instruments, the
sensitivity and speciﬁcity for 18S rRNA was 100%, with
100% concordance between the two instruments. The
sensitivity and speciﬁcity of the PF14_0367 assay on the
conventional instrument were 85.7% and 70%, re-
spectively. Many of the discrepant results were from sam-
ples with low-target transcript levels. Three of 24 results
were likely false positives, with two of these having Cq
values greater than 39. Two of the 24 results were false
negatives, with one of these (patient 21) having relatively
low Cq values in the standard RT-PCR and low parasite
densities by microscopy. The sensitivity and speciﬁcity of
the PF14_0367 assay in the portable instrument were
78.6% and 90%, respectively. One of 24 results was likely a
false positive, matching one of the false positives in the
conventional instrument (patient 18). Three of 24 results
were false negatives, with one matching a false negative in
the conventional instrument (patient 21), and the others
corresponding to samples that had relatively low Cq values
in the standard RT-PCR. For the PF14_0367 assay, the
concordance between the two instruments was 79.2%
(kappa = 0.583, 95% conﬁdence interval [CI] = 0.269–0.898),
with the discordant results observed in samples with low-
target transcript levels. Comparing the sensitivities and
speciﬁcities of the two assays revealed no signiﬁcant dif-
ference in the performance of the direct RT-PCR on the
conventional or portable real-time PCR instruments (Sup-
plemental Table 3).
DISCUSSION
The World Health Organization Global Technical Strategy
for Malaria provides a 15-year framework for malaria elimi-
nation that includes transforming malaria surveillance into a
core intervention as one of its three strategic “pillars”.39 For
the goals of this strategy to be realized, highly sensitive ﬁeld-
friendly surveillance toolsmust be developed.40 In this study,
we present a one-step RT-PCR assay that detected asexual
malaria parasites with a LOD of 10 parasites/mL. This assay,
if its sensitivity is conﬁrmed in ﬁeld settings, ismarkedlymore
sensitive than currently availablemicroscopy andHRP2-based
RDTs and has similar or higher sensitivity compared with
a LAMP assay targeting P. falciparum mitochondrial tar-
gets.41 The high sensitivity for gametocyte-speciﬁc mRNA
directly from blood on a portable real-time PCR instrument
indicates the tool may be highly relevant in monitoring
malaria transmission potential. The assay is sensitive
(1,000 parasites/mL) and speciﬁc for detection of mature
gametocyte targets. Although lower sensitivities for game-
tocytes have been reported with QT-NASBA (20 para-
sites/mL)21 and RT-LAMP (2 parasites/mL),16 the advantage
of the RT-PCR method reported here is that it does not
require nucleic acid puriﬁcation and uses small volumes
of blood (2.5 mL). The RT-PCR method may lose some sen-
sitivity because it is performed directly in the presence
of blood, which can degrade the RNA target and inhibit
polymerase activity.42,43 This assay also has some variability
in ampliﬁcation and melt curve proﬁles for asexual- and
sexual-stage transcripts emphasizing the need for optimi-
zation of primer sets, reaction conditions, and enzyme
18S rRNA in:
Gametocytes
Ring stages
PF14_0367 in:
Gametocytes
Ring stages
FIGURE 4. Detection ofPlasmodium falciparumPF14_0367mRNA and 18S rRNA in sexual- and asexual-stage parasites by direct RT-PCR.
Plasmodium falciparum strain NF54 stage V gametocytes and asexual ring stages puriﬁed 10 hours after merozoite invasion at 1 × 106
parasites/mL blood. Arrows indicate the ampliﬁcation curves for 18S rRNA in gametocytes and ring stages (0.8 cycle shift), and Pf14_0367
(8.3 cycle shift).
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concentration for each target. For simplicity of experimental
design and interpretation of SYBR-based ampliﬁcation and
melting curves, internal controls were not used in this study.
Nonetheless, the method presented here is sufﬁciently sen-
sitive and robust in detecting gametocytes in blood samples
on both a conventional real-time PCR instrument used in re-
search laboratory settings and a commercially available por-
table real-time PCRmachine intended for use in ﬁeld settings.
The choice of PF14_0367 as a gametocyte marker is sup-
ported in this study in Figure 4, showing greatly increased
expression in puriﬁed sexual compared with asexual stages.
Detection of the PF14_0367 transcript at low levels in asexual
stages most likely arises from contaminating sexual stages in
the preparation, and is not expected to interfere with in-
terpretation of the results.
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FIGURE 5. Detection of Plasmodium falciparum 18S rRNA and PF14_0367 mRNA in a portable real-time PCR instrument by direct RT-PCR.
Plasmodium falciparumRNA targetswere tested in a16-well portable real-timePCR instrument.Ampliﬁcation (A,C, andE) andmelt curve (B,D, and
F) data from the instrument are shown. For the18S rRNA assay, standard (1×) concentration of enzyme was used, and produced a LOD of 100
parasites/mL (A andB). For the PF14_0367 assay,mRNAwas detected in 3D7gametocytes at a LODof 10,000 parasites/mLwith 1× concentration
of enzyme (C andD) or 1,000 parasites/mLwith 5× concentration of enzyme (E andF). IndividualCq values obtained directly from the instrument are
listed in Supplemental Table 2. This ﬁgure appears in color at www.ajtmh.org.
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The performance of the RT-PCR assay on ﬁeld samples
from a region of high transmission in Cameroon indicates it
will be valuable as a transmission surveillance tool. To
assess the performance of this test, results were compared
with an RT-PCR reference standard using puriﬁed RNA
from the panel as template. The clinical sensitivity and
speciﬁcity of this test for malaria detection were excellent
in both conventional and portable instruments. With regard
to monitoring gametocyte transcripts in clinical samples,
the assay performance was also promising, considering
the relatively low levels of transcripts compared with 18S
rRNA. To reliably detect the lower levels of PF14_0367
transcripts, the assay performed in the portable instrument
required increased enzyme compared with the 18S rRNA
assay. The sensitivities of the conventional and portable
PF14_0367 assays based on comparison to the reference
standard (85.7% versus 78.6%) were not signiﬁcantly dif-
ferent, which was not unexpected considering the small
sample size. False negatives in both instruments tended to
correspond to samples with relatively high Cq values,
TABLE 2
Direct RT-PCR detection of 18SrRNA and PF14_0367 gametocyte mRNA in individuals from a high malaria transmission setting in Cameroon
18S rRNA RT-PCR PF14_0367 RT-PCR
Conventional Portable Ref§ Conventional Portable Ref
Patient* Cq† Tm (C)‡ Cq Tm (C) Cq Cq Tm (C) Cq Tm (C) Cq
1 17.9 77 18 78.5 16.7 33.4 78.5 31.9 79.2 39.4
18 76.5 20 79.1 16.7 32.7 78 32.4 79.6 38.2
2 14.4 77.5 16.8 79.3 17.8 32.1 78.5 33 79.8 35.7
14.3 77.5 16.5 79.1 17.8 32.1 78.5 32.9 80 34.7
3 20.6 77.5 27 78.9 22.8 36.2 79 36.2 79.7 31.7
21.2 77.5 26.8 79.8 22.8 35.5 79 36 79.6 32
4 26.3 76.5 31.1 79.1 29.5 – – – – –
26.4 77 NC – 29.5 – – – – –
5 17.4 77 18.5 78 14.4 33.7 78.5 31.3 78.8 27.3
17.3 77 19.4 78.4 14.4 33.1 78 30.8 79 26.7
6 25.4 77 31.9 79.3 25.6 – – – – –
26.1 77.5 33.5 79.8 25.6 – – – – –
7 20.1 77 24.9 78.3 14.1 38.9 78.5 – – 29.4
19.8 76.5 24.6 79.5 14.3 39 78.5 – – 29.1
8 16.2 76.5 19.6 77.8 15.6 34.7 77.5 33 78.8 33.2
16.2 76.5 18.6 78.1 15.6 34.1 77.5 33.9 79.4 34.1
9 21.3 76 NC 76.4 24.9 39.3 77.5 39.6 78.3 35.8
21.3 76 22.3 76.8 24.9 40.1 78.5 39.9 78.8 –
10 18.3 77 25.2 77 17.7 38.7 78 – – –
17.7 76.5 22.9 78.1 17.7 37.9 79 – – –
11 – – – – – – – – – –
– – – – – – – – – –
12 21.4 77.5 26.2 79 20.7 36.1 79 37.3 79.2 35.3
21.4 77.5 26.5 78.7 20.8 36.2 79 38.4 79.1 34.5
13 – – – – – – – – – –
– – – – – – – – – –
14 26.5 76.5 29.6 79 27.1 – – – – –
26.2 77 29.6 78.7 27.2 – – – – –
15 18.3 77 19.1 78 16.4 32.3 78 31 79 24.7
18 77 19.8 78.6 16.4 32.5 78 31.1 79.3 25.6
16 21 77.5 28.7 78.5 19.5 – – – – –
21.5 77.5 29 78.9 19.5 41.8 78.5 – – –
17 20 77 23.7 78.1 18.5 34.9 79 33.9 79.3 32.1
19.7 77 26.1 78.5 18.6 34.3 78.5 30.6 78.6 30.8
18 17.4 77 22.8 78.3 16.8 40.2 78 38.6 79.7 –
17.3 76.5 25.8 78.3 16.9 39.5 78.5 40.4 79.7 –
19 – – – – – – – – – –
– – – – – – – – – –
20 21.7 76.5 27.1 79.5 22.4 41.5 79 – – –
21.6 77 25.4 79.5 22.5 39.9 79 – – –
21 28.6 77 35.9 79 27.8 – – – – 28.4
28.4 77.5 NC – 27.5 – – – – 29.5
22 18.2 76 24.2 78.7 20.2 38.5 77 39.4 79 36.1
18.5 76.5 23.5 79.2 20.2 37.8 78 39 79.1 35.6
23 – – – – – – – – – –
– – – – – – – – – –
24 23.4 76.5 29.9 79 22.6 – – 40 79.1 40.1
23.3 77 29 80.2 22.6 – – 42.1 78.9 –
Cq = quantiﬁcation cycle; RT-PCR = reverse transcriptase polymerase chain reaction; Tm = melting temperature.
* Duplicate reactions performed for each patient sample are shown.
† Quantiﬁcation cycle value.Negative is indicatedas –, judgedbycutoff values for each target and instrument.NC indicates (1) no ampliﬁcation curve butCqvaluewas assigned, or (2) presenceof
an ampliﬁcation curve with no Cq value assigned; both considered negative.
‡Melting temperature. Negative (–) indicates no value assigned by the instrument.
§ Reference standard RT-PCR.
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suggesting thesemay have been low transcript samples on
the cusp of detection, or samples containing reaction in-
hibitors. Much the same can be said for the speciﬁcities of
the PF14_0367 assay in the portable and conventional in-
struments (90% versus 70%), which were also not signiﬁ-
cantly different and tended to occur in samples with high Cq
values. It is possible that the test performance has been af-
fected by the potential for single-stranded RNA target to be
degraded, especially in low transcript samples. Taken to-
gether, these results show much promise for the further de-
velopment of a direct RT-PCR assay. Future studies with an
expanded cohort of patients of varying levels of parasitemia,
including asymptomatic and submicroscopic patients, will
clarify these issues.
The portable instrument is a rugged, easily transportable,
AC-powered unit that performs 16 reactions per run in-
cluding controls. It is capable of onboard Cq and melting
curve processing and results display, avoiding the need for a
computer to run the instrument. Issues with venipuncture
may be overcome by ﬁngerprick collection of blood, as the
RT-PCR assay runs on small sample volumes. However, to
enable implementation in the ﬁeld, several challenges remain
to be addressed. Samples currently require cold storage to
preserve the RNA target, as do the liquid components of
the RT-PCR assay. In a previous study, we adapted PCR
diagnostics for the ﬁeld using desiccated hydrogels24 that
preserve enzyme activity at room temperature. For that
assay, samples could be added directly after collection to
desiccated hydrogels and run on the portable real-time
PCR instrument. We envision a similar approach for the
RT-PCR assay, which would be particularly effective in
avoiding degradation of the RNA template. The relatively
low throughput of the instrument may still require some
cold storage of samples in larger studies; however,
the low cost may make it possible to have multiple in-
struments running at once. The detection of RNA tar-
gets present in low abundance, as was the case with
PF14_0367, may also require increased enzyme and
modiﬁed master mix formulations, increasing the cost of
the assay in some cases. Despite these challenges, the
success of the direct RT-PCR on the portable real-time
PCR instrument coupled with the previous success of the
hydrogel assay provides a clear path for further testing in
the ﬁeld.
The detection of gametocytes by sensitive molecular
methods may be particularly relevant for epidemiological
studies examining the human infectious reservoir and
assessing the efﬁcacy of transmission-interrupting regi-
mens.6 Detection of gametocytes at sensitivities below the
threshold of microscopy, coupled with mosquito feeding
assays,may shed new light on infectiousness inmany areas
of study such as age-stratiﬁed populations, in longitudinal
studies measuring duration of infectiousness, and in
regions of low parasite density targeted by malaria elimi-
nation programs. Similarly, it is expected that sensitive
tools for gametocyte detection will be useful tomeasure the
efﬁcacy of transmission-blocking vaccines currently in
preclinical development and expected to enter clinical
testing in the next 5 years.44
CONCLUSION
The shift in focus from malaria control to elimination
programs requires a change in strategy that is underscored
by the need for more sensitive surveillance tools. The de-
velopment of molecular tests, particularly those of high
sensitivity and versatility to detect not only the presence of
malaria parasites, but other important characteristics such
as transmission potential, will be of great value in sustaining
elimination efforts and preventing reintroduction of dis-
ease. The use of simple, RNA-based diagnostics such as
the direct RT-PCR assay described here, addresses many
of the speciﬁc needs of countries on the path to malaria
eradication.
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